✦ LIBER ✦

Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP)

✍ Scribed by H.W. Bruckner; C.J. Cohen; G. Deppe; B. Kabakow; R. Wallach; L. Ratner; James F. Holland

Book ID: 119052072
Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 258 KB
Volume: 12
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(81)90144-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy of advanced ova

Combination chemotherapy of advanced ovarian cancer with cyclophosphamide (C), hexamethylmelamine (H), adriamycin (A) and diamminedichloroplatinum (D) — The “CHAD” regimen

✍ S.E. Vogl; M. Pagano; B.H. Kaplan; A. Canalog; E. Greenwald; J. Arseneau; S. Far 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Treatment of advanced ovarian cancer wit

Treatment of advanced ovarian cancer with combination chemotherapy using cyclophosphamide, adriamycin and cis-platinum

✍ R. MILSTED; G. SANGSTER; S. KAYE; K. CALMAN; J. CORDINER; W. SOUTTER; W. BARR; D 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

Cyclophosphamide, adriamycin, and cis-di

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer

✍ Edward T. Creagan; Thomas R. Fleming; John H. Edmonson; James N. Ingle; John E. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 2 views

Treatment of advanced ovarian cancer: A

Treatment of advanced ovarian cancer: A randomised trial comparing adriamycin or 4′epi-adriamycin in combination with cisplatin and cyclophosphamide

✍ Bezwoda, W. R. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'

Treatment of advanced ovarian cancer wit

Treatment of advanced ovarian cancer with sequential combination chemotherapy

✍ Thomas W. Griffin; Richard A. Hunter; Andrew I. Cederbaum; Won K. Tak; Allen D. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

Chemotherapy for advanced head and neck

Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): Preliminary assessment of a one-day vs. three-day drug regimen

✍ Edward T. Creagan; Thomas R. Fleming; John H. Edmonson; James N. Ingle; John E. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 3 views

Fourteen patients with advanced head and neck carcinomas received a monthly intravenous regimen of Adriamycin, 40 mg/m2, day 1; cyclophosphamide, 400 mg/m2, day 3; and cis-diamminedichloroplatinum, 20 mg/m2/1 hour, days 1-3 (CAP-3). A regression rate of only 7% (0112 squamous cell carcinomas; 112 ad